Trademarkia Logo

Canada

C$
FULCRUM
REGISTERED

on 15 Jun 2022

Last Applicant/ Owned by

Fulcrum Therapeutics, Inc.

26 Landsdowne StreetCambridge MA 02139

US

Serial Number

2021555 filed on 14th Nov 2019

Registration Number

TMA1131707 registered on 15th Jun 2022

Registration expiry Date

14th Nov 2029

Correspondent Address

SMART & BIGGAR LP

Scotia Plaza, 40 King Street West40th FloorToronto

ONTARIO

CA

M5H3Y2

FULCRUM

Trademark usage description

pharmaceuticals for use in the treatment of neuromuscular, hematological, rare and genetically defined diseases and disorders, namely, facioscapulohum Read More

Classification Information


Class [005]
Pharmaceuticals for use in the treatment of neuromuscular, hematological, rare and genetically defined diseases and disorders, namely, facioscapulohumeral muscular dystrophy (FSHD), sickle cell disease (SCD) and beta thalassemia


Classification kind code

11

Class [042]
Provision of medical and scientific research information in the field of pharmaceutical development via an online searchable database; scientific and medical research and information services in the field of pharmaceutical development.


Classification kind code

11

Mark Details


Serial Number

2021555

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 22
on 3rd Aug 2021
Search Recorded
Submitted for opposition 20
on 3rd Aug 2021
Examiner's First Report
Submitted for opposition 223
on 3rd Aug 2021
Total Provisional Refusal
Submitted for opposition 256
on 9th Feb 2021
Notification of Possible Opposition Sent
Submitted for opposition 48
on 2th Jun 2020
Agent Changed
Submitted for opposition 257
on 9th Apr 2020
Designation Notification - Madrid Protocol
Submitted for opposition 31
on 8th Apr 2020
Formalized
Submitted for opposition 1
on 8th Apr 2020
Created
Submitted for opposition 30
on 14th Nov 2019
Filed
Submitted for opposition 228
on 14th Nov 2019
International Registration